66
Participants
Start Date
August 31, 2013
Primary Completion Date
September 30, 2014
Study Completion Date
September 30, 2014
NanoJect device (DebioJect™)
The investigational device used in this study is the NanoJect™ device developed by Debiotech company.
Classical syringe (1mL Becton Dickinson (BD) Luer-Lock™) with a 25 Guage (G) needle (Terumo® Neolus)
The comparator device used for standard ID injections is a classical syringe (1mL BD Luer-Lock™) with a 25G needle (Terumo® Neolus)
Classical syringe (1mL BD Luer-Lock™) with a 22G needle (Terumo® Neolus)
The comparator device used for standard IM injections is a classical syringe (1mL BD Luer-Lock™) with a 22G needle (Terumo® Neolus)
Vaccin rabique Pasteur®
Placebo
Sodium Chloride (NaCl) 0,9%; B. Braun
University of Lausanne Hospitals
OTHER